<DOC>
	<DOCNO>NCT02731885</DOCNO>
	<brief_summary>The goal study determine impact food absorption ABX464 .</brief_summary>
	<brief_title>Food Effect Pharmacokinetic Parameters ABX464</brief_title>
	<detailed_description>This phase I , single-center , open-label , two-treatment , food-effect , randomize study 40 healthy Caucasian male subject order determine impact food absorption ABX464 . The two different treatment following : - Treatment A = 50mg ABX464 ( two 25mg capsule ) /Fasted - Treatment B = 50mg ABX464 ( two 25mg capsule ) / Fed This study consist two group : - Group 1 - single dose assessment , two-period , two-treatment , cross-over : 20 subject receive single dose 50mg ABX464 fed fast condition , separate wash-out period least 45 day . - Group 2 - multiple dose assessment : 20 subject receive 50mg ABX464 every 3 day 10 day fast fed condition .</detailed_description>
	<criteria>Healthy Caucasian male subject , 1855 year age Body Mass Index ( BMI ) 1728 kg/mÂ² . Certified healthy comprehensive clinical assessment ( detailed medical history complete physical examination ) Normal vital sign 10 minute rest supine position : 90 mmHg &lt; systolic blood pressure &lt; 140 mmHg , 50 mmHg &lt; diastolic blood pressure &lt; 90 mmHg , 40 bpm &lt; heart rate &lt; 100 bpm . Normal automatic 12lead ECG ( incomplete right bundle branch block accept ) judge non clinically significant . Clinical laboratory test ( hematology , blood chemistry , urinalysis ) must within normal limit clinically acceptable Investigator Sponsor . Subjects must willing give write informed consent prior study enrollment able adhere restriction examination schedule . Individuals history significant medical disorder require physician 's care ( cardiovascular , pulmonary , gastrointestinal , hepatic , renal , metabolic , hematological , neurologic , psychiatric , systemic , infectious disease ; acute infectious disease sign acute illness ) Frequent headaches / migraine , recurrent nausea / vomiting ( twice month ) . Presence history drug allergy , allergic disease diagnose treated physician . Individuals history clinically significant local systemic infectious disease within 4 week prior drug administration . Any individual comply requirement use drug paracetamol least 2 week prior study alcohol within 48 hour prior drug administration . Individuals positive hepatitis B virus , hepatitis C virus HIV . History presence drug alcohol abuse ( positive urine drug screen , positive alcohol breath test ) . Smoking 5 cigarette equivalent / day , unable stop smoking study . Excessive consumption beverage xanthine base ( &gt; 4 cup glass / day ) . Subject likely unable eat entirely standard high fat breakfast within allocated time . Individuals donate blood within precede 3 month . Individuals refuse use effective method contraception begin study 3 month dose . Individuals forfeiture freedom administrative legal obligation guardianship</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>